Cargando…
Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases
BACKGROUND: Data on the effectiveness of SARS-CoV-2 vaccines and the durability of protection against the prevalent Omicron variant are scarce, especially in patients with autoimmune rheumatic diseases (AIRDs). Hence, we prospectively studied Omicron breakthrough infections in patients with AIRDs an...
Autores principales: | Benny, Libin, Mehta, Pankti, Ahmed, Sakir, Paul, Aby, Sukumaran, Aswathy, Mohanan, Manju, Vijayan, Anuroopa, Kaveri, K., Padmaja, R., Shenoy, Padmanabha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082437/ https://www.ncbi.nlm.nih.gov/pubmed/37029793 http://dx.doi.org/10.1007/s00296-023-05314-5 |
Ejemplares similares
-
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021) -
Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
por: Mehta, Pankti, et al.
Publicado: (2022) -
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
por: Skaria, Teny Grace, et al.
Publicado: (2022) -
Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022) -
Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity
por: Menon, Aparna R., et al.
Publicado: (2022)